We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne profile page

Managing Editor

 at Technology Networks


As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Education


University of Kent  

Nottingham Trent University  


Areas of Expertise



Got a Question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 409
Microphysiological Systems: Approaches, Applications and Opportunities content piece image
Article

Microphysiological Systems: Approaches, Applications and Opportunities

In this article, we highlight advances in the field that have been instrumental to the development of microphysiological systems, as well as key applications and future opportunities.
Caffeine Buzz Boosts Bees’ Ability To Find Specific Blooms content piece image
News

Caffeine Buzz Boosts Bees’ Ability To Find Specific Blooms

Researchers have demonstrated that by supplying bees with caffeine it is possible to boost their ability to remember the smell of a specific flower. The team’s findings were published in Current Biology, July 28, 2021.
mRNA COVID-19 Vaccines: Safety of Second Dose Following First-Dose Allergic Reactions content piece image
News

mRNA COVID-19 Vaccines: Safety of Second Dose Following First-Dose Allergic Reactions

A multicenter, retrospective study has been conducted to assess the safety of a second dose of mRNA COVID-19 vaccine in patients with allergic reactions to the first dose. All patients with allergic reactions to the first dose, who went on to receive a second dose, safely completed their course, with 20% reporting mild symptoms.
Inhaled Nanobodies: A Potential Treatment for COVID-19 content piece image
Article

Inhaled Nanobodies: A Potential Treatment for COVID-19

Dr. Yi Shi, assistant professor in the department of cell biology at the University of Pittsburgh and colleagues are exploring the potential of nanobodies as a treatment for COVID-19. The team recently published findings from preclinical studies on the use of a nanobody called Pittsburgh inhalable Nanobody-21 (PiN-21) that targets the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein.
Developing Thermostable Vaccines To Improve Accessibility Worldwide content piece image
Industry Insight

Developing Thermostable Vaccines To Improve Accessibility Worldwide

We spoke to Ozgur Tuncer, chief executive officer of Stablepharma to find out more about the company’s thermo-stabilization technology called StablevaX™ and how it is being used as a complementary technology for COVID-19 vaccines. He also highlights the impact “fridge-free” vaccines could have more generally.
Creating “Crave-Worthy” Plant-Based Foods content piece image
Industry Insight

Creating “Crave-Worthy” Plant-Based Foods

Technology Networks spoke to Stefan Baier, head of food science at Motif FoodWorks, to learn more about the exclusive access to transformative plant-based food technologies the company has recently been granted. He also highlights the role plant-based foods play in protecting the environment and the importance of flavor and texture when developing plant-based foods.
Unraveling the Romanesco Cauliflower’s Spiraling Structure content piece image
News

Unraveling the Romanesco Cauliflower’s Spiraling Structure

A team of researchers has identified the genes responsible for the spiraling conical structures that comprise the Romanesco cauliflower, and have replicated these patterns in a small flowering plant called Arabidopsis thaliana.
Connecting Biobanks With Biotech and Pharma Successfully content piece image
Industry Insight

Connecting Biobanks With Biotech and Pharma Successfully

Technology Networks recently had the pleasure of speaking with Robert Hewitt, founder and manager of Biosample Hub, a unique platform designed to connect biotech and pharmaceutical companies with biobanks. Biosample Hub aims to help scientists obtain the samples they need to support the testing and development of novel therapeutics, diagnostics and vaccines, while establishing and maintaining biospecimen provenance information.
DNA Analysis at the Single-Nuclei Level content piece image
Industry Insight

DNA Analysis at the Single-Nuclei Level

We spoke with Yan Zhang, PhD, CEO of Mission Bio to find out more about single-nuclei DNA analysis using the Tapestri platform.
Cancer Immunotherapy content piece image
Infographic

Cancer Immunotherapy

Immunotherapy is a specific type of treatment that utilizes the body’s immune system to fight diseases such as cancer. Download this infographic to discover various types of immunotherapy and the potential of mRNA technology in this space.
Advertisement